ArticleJournal for immunotherapy of cancer2023

Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab.

Eric D Routh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.